← FDA Drug Approvals (Drugs@FDA)

LYVISPAH

NDA · New Drug Application · Sponsor: STRIDES PHARMA INTL · Approved 2021-11-22

Drug application

FDA Application #

NDA215422

Application type

New Drug Application

Brand name

LYVISPAH

Generic name

BACLOFEN

Active ingredients

BACLOFEN

Dosage form

GRANULE

Route

ORAL

Marketing status

Discontinued

Sponsor

STRIDES PHARMA INTL

Manufacturer

Amneal Pharmaceuticals LLC

First approval

2021-11-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown